Free whitepaper
The Bioavailability Gap
How overlooked formulation challenges are constraining innovation across nutraceuticals
Many products focus on how much of an ingredient is in a formulation, not on how much of it is actually released and absorbed. Using berberine as a case study, this whitepaper shows why promising ingredients underperform and how delivery technology changes that.
Opens a short form. Fill it in to receive the PDF.
What's inside
Four topics, one question: what actually reaches the body?
01
From ingredient potential to usable health value
Why the amount of an active in a product says little about what reaches the body.
02
From ingredient-led to delivery-led innovation
How the focus of product development is shifting from the ingredient list to release and absorption.
03
Case study: delivery-led innovation with berberine
Low bioavailability, high doses and poor taste, and what delivery technology does about them.
04
The role of ingredient delivery beyond berberine
What the berberine case means for other natural ingredients.
Why it matters
For brands that want products to stand out, delivery is the next step
The nutraceutical market is moving fast, driven by consumers who expect effective, convenient and science-backed products. The whitepaper is written for product developers, formulators and brand managers who want to understand why bioavailability decides whether an ingredient delivers on its promise.
Quantity is not efficacy
Success depends less on which ingredients are used than on how well they work in the body.
Three common barriers
Low bioavailability, high dosage needs and poor taste hold back promising ingredients.
Delivery as the lever
Advanced delivery technologies improve efficacy, user experience and room for product innovation.
FAQ
Questions about the whitepaper
Is the whitepaper free?
Yes. Fill in the short form to receive the PDF.
What is the whitepaper about?
It looks at why many nutraceutical ingredients underperform because of low bioavailability, high dosage needs and poor taste, with berberine as a case study, and at the role of delivery technologies such as OPTISOLV® Technology.
Who is the whitepaper for?
Product developers, formulators and brand managers in nutraceuticals and functional foods.
Free whitepaper
Get The Bioavailability Gap
22 pages on bioavailability, delivery-led innovation and berberine as a case study.